Please provide your email address to receive an email when new articles are posted on . Weiner: Is insulin pump therapy recommended for people with type 2 diabetes who require basal-bolus therapy?

Dr. Marie McDonnell, the director of the Brigham Diabetes Program at Brigham and Women’s Hospital in Boston, told TODAY that basal insulin is a long-acting insulin therapy that helps the body process ...

Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.* Dexcom Smart Basal is FDA cleared and now the ...

These authors evaluated the GRI conjugate according to its capacity to replace both prandial and basal needs using laboratory-based assessments and preclinical mouse and mini-pig models (Figure 1).

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Insulin icodec-abae is a 700 U/mL injectable insulin ...

The MarketWatch News Department was not involved in the creation of this content. -- Awiqli(R) (insulin icodec-abae) injection is the first-ever once-weekly basal insulin approved by the FDA1 -- ...

COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in ...

With the prevalence of diabetes quadrupling in recent decades and currently impacting more than 500 million people in the world, it is no surprise that the technology for insulin delivery has also ...

PLAINSBORO, N.J., March 26, 2026 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the ...